Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa.

Malacrida A, Cavalloro V, Martino E, Cassetti A, Nicolini G, Rigolio R, Cavaletti G, Mannucci B, Vasile F, Giacomo MD, Collina S, Miloso M.

Molecules. 2019 Jul 9;24(13). pii: E2500. doi: 10.3390/molecules24132500.

2.

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways.

Magistroni V, Mauri M, D'Aliberti D, Mezzatesta C, Crespiatico I, Nava M, Fontana D, Sharma N, Parker W, Schreiber A, Yeung D, Pirola A, Readelli S, Massimino L, Wang P, Khandelwal P, Citterio S, Viltadi M, Bombelli S, Rigolio R, Perego R, Boultwood J, Morotti A, Saglio G, Kim DW, Branford S, Gambacorti-Passerini C, Piazza R.

Haematologica. 2019 Sep;104(9):1789-1797. doi: 10.3324/haematol.2017.179937. Epub 2019 Feb 28.

3.

Oxaliplatin induces pH acidification in dorsal root ganglia neurons.

Riva B, Dionisi M, Potenzieri A, Chiorazzi A, Cordero-Sanchez C, Rigolio R, Carozzi VA, Lim D, Cavaletti G, Marmiroli P, Distasi C, Genazzani AA.

Sci Rep. 2018 Oct 10;8(1):15084. doi: 10.1038/s41598-018-33508-6.

4.

Artificial apolipoprotein corona enables nanoparticle brain targeting.

Dal Magro R, Albertini B, Beretta S, Rigolio R, Donzelli E, Chiorazzi A, Ricci M, Blasi P, Sancini G.

Nanomedicine. 2018 Feb;14(2):429-438. doi: 10.1016/j.nano.2017.11.008. Epub 2017 Nov 21.

PMID:
29157979
5.

Size and specimen-dependent strategy for x-ray micro-ct and tem correlative analysis of nervous system samples.

Parlanti P, Cappello V, Brun F, Tromba G, Rigolio R, Tonazzini I, Cecchini M, Piazza V, Gemmi M.

Sci Rep. 2017 Jun 6;7(1):2858. doi: 10.1038/s41598-017-02998-1.

6.

ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.

Dal Magro R, Ornaghi F, Cambianica I, Beretta S, Re F, Musicanti C, Rigolio R, Donzelli E, Canta A, Ballarini E, Cavaletti G, Gasco P, Sancini G.

J Control Release. 2017 Mar 10;249:103-110. doi: 10.1016/j.jconrel.2017.01.039. Epub 2017 Jan 31.

PMID:
28153761
7.

Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma.

Redaelli S, Ceccon M, Antolini L, Rigolio R, Pirola A, Peronaci M, Gambacorti-Passerini C, Mologni L.

Oncotarget. 2016 Nov 8;7(45):72886-72897. doi: 10.18632/oncotarget.12128.

8.

Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.

Ceccon M, Merlo MEB, Mologni L, Poggio T, Varesio LM, Menotti M, Bombelli S, Rigolio R, Manazza AD, Di Giacomo F, Ambrogio C, Giudici G, Casati C, Mastini C, Compagno M, Turner SD, Gambacorti-Passerini C, Chiarle R, Voena C.

Oncogene. 2016 Jul 21;35(29):3854-3865. doi: 10.1038/onc.2015.456. Epub 2015 Dec 14.

9.

Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling.

Tambalo S, Peruzzotti-Jametti L, Rigolio R, Fiorini S, Bontempi P, Mallucci G, Balzarotti B, Marmiroli P, Sbarbati A, Cavaletti G, Pluchino S, Marzola P.

J Neurosci. 2015 Jul 8;35(27):10088-100. doi: 10.1523/JNEUROSCI.0540-15.2015.

10.

In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib.

Redaelli S, Perini P, Ceccon M, Piazza R, Rigolio R, Mauri M, Boschelli F, Giannoudis A, Gambacorti-Passerini C.

J Hematol Oncol. 2015 Jul 7;8:81. doi: 10.1186/s13045-015-0179-4.

11.

Dihydrotestosterone as a Protective Agent in Chronic Experimental Autoimmune Encephalomyelitis.

Giatti S, Rigolio R, Romano S, Mitro N, Viviani B, Cavaletti G, Caruso D, Garcia-Segura LM, Melcangi RC.

Neuroendocrinology. 2015;101(4):296-308. doi: 10.1159/000381064. Epub 2015 Feb 26.

PMID:
25765436
12.

Myricetin and naringenin inhibit human squamous cell carcinoma proliferation and migration in vitro.

Maggioni D, Nicolini G, Rigolio R, Biffi L, Pignataro L, Gaini R, Garavello W.

Nutr Cancer. 2014;66(7):1257-67. doi: 10.1080/01635581.2014.951732. Epub 2014 Sep 25.

PMID:
25256786
13.

Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis.

Maggioni D, Garavello W, Rigolio R, Pignataro L, Gaini R, Nicolini G.

Int J Oncol. 2013 Nov;43(5):1675-82. doi: 10.3892/ijo.2013.2072. Epub 2013 Aug 21.

14.

Functionalized mesoporous silica nanoparticles: a possible strategy to target cancer cells reducing peripheral nervous system uptake.

Ceresa C, Nicolini G, Rigolio R, Bossi M, Pasqua L, Cavaletti G.

Curr Med Chem. 2013;20(20):2589-600.

PMID:
23627934
15.

Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Giatti S, Boraso M, Abbiati F, Ballarini E, Calabrese D, Santos-Galindo M, Rigolio R, Pesaresi M, Caruso D, Viviani B, Cavaletti G, Garcia-Segura LM, Melcangi RC.

J Neuroimmune Pharmacol. 2013 Mar;8(1):238-50. doi: 10.1007/s11481-012-9385-9. Epub 2012 Jun 30.

PMID:
22870853
16.

Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis.

Giatti S, Caruso D, Boraso M, Abbiati F, Ballarini E, Calabrese D, Pesaresi M, Rigolio R, Santos-Galindo M, Viviani B, Cavaletti G, Garcia-Segura LM, Melcangi RC.

J Neuroendocrinol. 2012 Jun;24(6):851-61. doi: 10.1111/j.1365-2826.2012.02284.x.

PMID:
22283602
17.

Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.

Re F, Cambianica I, Zona C, Sesana S, Gregori M, Rigolio R, La Ferla B, Nicotra F, Forloni G, Cagnotto A, Salmona M, Masserini M, Sancini G.

Nanomedicine. 2011 Oct;7(5):551-9. doi: 10.1016/j.nano.2011.05.004. Epub 2011 May 20.

PMID:
21658472
18.

Neuropathological changes in the peripheral nervous system and spinal cord in a transgenic mouse model of Niemann-Pick disease type A.

Marmiroli P, Rodriguez-Menendez V, Rigamonti L, Tonoli E, Rigolio R, Cavaletti G, Tredici G, Vercelli A.

Clin Neuropathol. 2009 Jul-Aug;28(4):263-74.

19.

Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies.

Chiorazzi A, Nicolini G, Canta A, Oggioni N, Rigolio R, Cossa G, Lombardi R, Roglio I, Cervellini I, Lauria G, Melcangi RC, Bianchi R, Crippa D, Cavaletti G.

Neurobiol Dis. 2009 Aug;35(2):270-7. doi: 10.1016/j.nbd.2009.05.006. Epub 2009 May 21.

PMID:
19464369
20.

Actively induced EAE in Lewis rats: characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease.

Rigolio R, Biffi A, Oggioni N, Cavaletti G.

J Neuroimmunol. 2008 Aug 13;199(1-2):67-74. doi: 10.1016/j.jneuroim.2008.05.008. Epub 2008 Jun 24.

PMID:
18572253
21.

The mitochondrial genome, a growing interest inside an organelle.

Crimi M, Rigolio R.

Int J Nanomedicine. 2008;3(1):51-7. Review.

22.

A new device to study ex-vivo the effects of extracorporeal photochemotherapy on the immune system.

Rigolio R, Perseghin P, Jonsson S, Petersson J, Cavaletti G, Cilio CM.

J Photochem Photobiol B. 2007 Jul 27;88(1):68-75. Epub 2007 May 18.

PMID:
17583527
23.

Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis.

Villa D, Miloso M, Nicolini G, Rigolio R, Villa A, Cavaletti G, Tredici G.

Mol Cancer Ther. 2005 Sep;4(9):1439-47.

24.

Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis.

Rigolio R, Miloso M, Nicolini G, Villa D, Scuteri A, Simone M, Tredici G.

Neurochem Int. 2005 Feb;46(3):205-11. Epub 2004 Dec 31.

PMID:
15670636
25.

Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis.

Cavaletti G, Cavalletti E, Crippa L, Di Luccio E, Oggioni N, Mazzanti B, Biagioli T, Sala F, Sala V, Frigo M, Rota S, Tagliabue E, Stanzani L, Galbiati S, Rigolio R, Zoia C, Tredici G, Perseghin P, Dassi M, Riccio P, Lolli F.

J Neuroimmunol. 2004 Jun;151(1-2):55-65.

PMID:
15145604
26.

Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.

Cavaletti G, Petruccioli MG, Marmiroli P, Rigolio R, Galbiati S, Zoia C, Ferrarese C, Tagliabue E, Dolci C, Bayssas M, Griffon Etienne G, Tredici G.

Anticancer Res. 2002 Nov-Dec;22(6C):4199-204.

PMID:
12553056
27.

Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells.

Nicolini G, Rigolio R, Scuteri A, Miloso M, Saccomanno D, Cavaletti G, Tredici G.

Neurochem Int. 2003 Apr;42(5):419-29.

PMID:
12510025
28.

Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.

Nicolini G, Rigolio R, Miloso M, Bertelli AA, Tredici G.

Neurosci Lett. 2001 Apr 13;302(1):41-4.

PMID:
11278107
29.

Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.

Giardina GA, Artico M, Cavagnera S, Cerri A, Consolandi E, Gagliardi S, Graziani D, Grugni M, Hay DW, Luttmann MA, Mena R, Raveglia LF, Rigolio R, Sarau HM, Schmidt DB, Zanoni G, Farina C.

Farmaco. 1999 Jun 30;54(6):364-74.

PMID:
10443017
30.

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).

Giardina GA, Raveglia LF, Grugni M, Sarau HM, Farina C, Medhurst AD, Graziani D, Schmidt DB, Rigolio R, Luttmann M, Cavagnera S, Foley JJ, Vecchietti V, Hay DW.

J Med Chem. 1999 Mar 25;42(6):1053-65.

PMID:
10090788
31.

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.

Giardina GA, Sarau HM, Farina C, Medhurst AD, Grugni M, Raveglia LF, Schmidt DB, Rigolio R, Luttmann M, Vecchietti V, Hay DW.

J Med Chem. 1997 Jun 6;40(12):1794-807.

PMID:
9191956
32.

2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.

Giardina GA, Sarau HM, Farina C, Medhurst AD, Grugni M, Foley JJ, Raveglia LF, Schmidt DB, Rigolio R, Vassallo M, Vecchietti V, Hay DW.

J Med Chem. 1996 Jun 7;39(12):2281-4. No abstract available.

PMID:
8691422

Supplemental Content

Loading ...
Support Center